isatuximab,dexamethasone,mezigdomide,carfilzomib,bortezomib,elotuzumab,pomalidomide,bms-986354,cc-99285,modakafusp alfa,daratumumab
amgen,sanofi,bms,janssen,takeda
['modakafusp', 'nct03989414', ' pom ', 'bms-986354', 'lymphoma', 'multiple myeloma', 'borte', 'celmod', 'bms']
promising new therapies in multirefractory multiple myeloma presented at oral session today at #ahs22 including: modakafusp alfa (dr dt vogl) , next-processed cart bms-986354 (dr l.costa) &amp; celmod megzidomide (dr p richardson) 
Dr.Hematology & Transfusion Hospital U de La Princesa & H.U.Quironsalud Madrid,@UAM Professor, President @fleucemiaylinfo @sehh_es @hematologiamadr @quironsalud